Trial intelligence / Profile preview

Norepinephrine plus mini-fluid challenge to predict fluid responsiveness during general anesthesia hypotension

ChiCTR2500107190Phase 4Not yet recruiting

Sponsor
Subei People's Hospital
Start
Aug 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of norepinephrine in intraoperative hypotension (IOH), sponsored by Subei People's Hospital. Primary endpoints: heart rate, mean arterial pressure and 3 more. Planned start Aug 2025; status: not yet recruiting.

02

Drugs

norepinephrine
03

Conditions

intraoperative hypotension (IOH)

Beyond the preview

Go deeper on ChiCTR2500107190.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500107190.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call